$1.60
+
$0.07 (4.58%)
End-of-day quote: 05/17/2024
NasdaqGS:APYX
Apyx Medical Annual Report
Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2010 | 2008 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
$52.35M | $44.51M | $48.52M | $27.71M | $28.24M | $16.61M | $10.23M | $8.82M | $29.52M | $24.23M | $28.10M | |
GM % | Gross Margin % |
|
64.49% | 65.45% | 69.26% | 63.17% | 67.63% | 65.20% | 67.99% | 58.01% | 42.54% | 41.22% | 42.17% | |
OM | Operating Margin |
|
-37.63% | -52.94% | -29.78% | -72.47% | -70.37% | -81.51% | -120.78% | -129.18% | -23.67% | -6.05% | 4.59% | |
EPS | Earnings Per Share |
|
$0.00 | $-0.53 | $-0.67 | $-0.44 | $-0.35 | $-0.58 | $-0.26 | $-0.12 | $-0.14 | $-0.29 | $-0.09 | $0.11 |
Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Sha. | Shares |
|
34.64m | 34.6m | 34.41m | 34.29m | 34.17m | 33.7m | 32.88m | 30.86m | 27.05m | 17.56m | 16.8m | |
OCF | Operating Cash Flow |
|
$-5.25M | $-20.28M | $-10.45M | $-16.07M | $-18.48M | $-20.88M | $-3.70M | $-2.84M | $-5.79M | $-0.53M | $0.74M | |
FCF | Free Cash Flow |
|
$-15.55M | $-21.29M | $-11.17M | $-16.65M | $-19.78M | $-21.37M | $-5.51M | $-3.13M | $-6.21M | $-0.73M | $-3.73M | |
FCFS | Free Cash Flow Per Share |
|
$-0.17 | $-0.62 | $-0.33 | $-0.49 | $-0.58 | $-0.64 | $-0.14 | $-0.11 | $-0.26 | $-0.04 | $-0.24 |